8.10

5.74% 0.44

Rockwell Medical Inc (RMTI)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Rockwell Medical Inc stock is traded at $8.10, with a volume of 58,633. It is up +5.74% in the last 24 hours and up +3.18% over the past month. Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.

Previous Close:

$7.66

Open:

$7.755

24h Volume:

58,633

Relative Volume:

2.16

Market Cap:

$32.65M

Revenue:

$67.68M

Net Income/Loss:

$-5.40M

P/E Ratio:

-55.10

EPS:

-0.147

Net Cash Flow:

$1.76M

1W Performance:

+1.00%

1M Performance:

+3.18%

6M Performance:

-11.68%

1Y Performance:

-32.50%

1-Day Range:

$7.36

$8.241

1-Week Range:

$7.502

$8.10

52-Week Range:

$4.885

$12.90

Rockwell Medical Inc Stock (RMTI) Company Profile

Name

Rockwell Medical Inc

Sector

Healthcare (1051)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

(800) 449-3353

Address

30142 WIXOM ROAD, WIXOM, NJ

Employee

157

Twitter

@rockwellmedical

Next Earnings Date

2026-11-11

Latest SEC Filings

RMTI's Discussions on Twitter

Compare RMTI vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RMTI Rockwell Medical Inc	8.10	32.65M	67.68M	-5.40M	1.76M	-0.147
TAK Takeda Pharmaceutical Co Adr	19.63	62.71B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	41.25	48.11B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.965	43.82B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	78.69	32.51B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	548.81	23.54B	3.17B	1.29B	1.01B	27.09

Rockwell Medical Inc Stock (RMTI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-14-24	Initiated	Rodman & Renshaw	Buy
Jun-24-19	Initiated	Piper Jaffray	Overweight
May-13-19	Initiated	H.C. Wainwright	Buy
Nov-08-16	Downgrade	BofA/Merrill	Neutral → Underperform
Mar-01-16	Downgrade	Stifel	Buy → Hold
Aug-13-15	Initiated	Morgan Stanley	Underweight
Jan-27-15	Reiterated	Oppenheimer	Outperform
Jan-07-15	Initiated	Oppenheimer	Outperform
Aug-14-14	Initiated	FBR Capital	Underperform
Dec-19-13	Initiated	Chardan Capital Markets	Buy
Nov-06-13	Reiterated	Summer Street Research	Buy
Sep-05-13	Reiterated	Summer Street Research	Buy
Aug-02-13	Reiterated	Summer Street Research	Buy
Apr-11-12	Initiated	Summer Street Research	Buy
Mar-12-12	Initiated	Stifel Nicolaus	Buy
Jan-03-12	Initiated	Canaccord Genuity	Buy
Dec-10-09	Initiated	JMP Securities	Mkt Outperform
Oct-12-09	Initiated	Wedbush Morgan	Outperform

View All

Rockwell Medical Inc Stock (RMTI) Latest News

Oct 14, 2026

Dialysis products will be on display in Denver during Kidney Week, Oct. 21-25 - Stock Titan

Oct 14, 2026

Oct 13, 2026

Rockwell Medical earns Fortune ranking. Rockwell Medical stock is valued at USD 31.0 million - ad-hoc-news.de

Oct 13, 2026

Oct 11, 2026

Live Rockwell Medical, Inc. (RMTI) Technical Analysis - Traders Union

Oct 11, 2026

Oct 08, 2026